The purpose of this comprehensive
forecast report presented by Fact.MR is to elaborate the various market
projections impacting the global biobanking
equipment market during the period through 2017-2022. This
assessment delivers high-end statistics concerning market size, growth in
trends and revenue share (US& Mn) linked to different geographies and
segmentation types. Readers can acquire precise insights about market growth
trends along with upcoming opportunities that are expected to reshape the
overall structure of the biobanking equipment market during the forecast
period.
Request for
a Free Sample Report of Concerned Market -https://www.factmr.com/connectus/sample?flag=RC&rep_id=250
Rising number of research
activities related to genomics to study nature of diseases, along with the
advancements in biobanking are expected to impact growth of the global
biobanking equipment market. This FactMR report analyzes the expansion of
global biobanking equipment market till date, and provides key insights on the
growth of the market during the forecast period, 2017-2022. The scope of
FactMR’s report is to analyze the global Biobanking Equipment Market for the
forecast period 2017-2022 and provide readers an unbiased and accurate
analysis. Medical device manufacturers, research institutes, and raw material
suppliers in the global biobanking equipment market can benefit from the
analysis offered in this report. This report offers a comprehensive analysis,
which can be of interest to leading trade magazines and medical journals
pertaining to biobanking equipment. The report commences with a brief
information of the global biobanking equipment market. Bio banking equipment
are equipment used in the biorepository, which stores biological samples for
research purposes. Using biobanking equipment, researchers conduct tests, or
perform analysis on specimens stored in a biobank. Along with equipment,
consumables, software and services play an important role in helping
researchers to study various types of diseases.
A major factor driving growth of
the biobanking equipment market is growing demand for personalized medicine,
which can be attributed to high unmet medical requirements for developing
effective therapies. Personalized medicine implies treatments based on
preferences, needs, and characteristics of patients. Individuals across the
globe have been witnessed to bank their tissues and stem cells, in case any
future treatment is required. Development of personalized medicine critically
needs individual samples with annotated pathological and clinical data. Several
research organizations are focusing on exploring ways for developments in
personalized treatments with the help of biological samples. For example, in
the previous year, Illumina signed 4 deals, related to biobanking, with the
Vanderbilt University, Partners HealthCare, the Montreal Heart Institute, and
the University of Colorado, with an aim of developing personalized medicines,
and improving the overall healthcare system. This will positively impact growth
of the global biobanking equipment market. Other factors influencing the market
growth include growing need for discovery and development of cost-effective
drugs, rise in private as well as government funding for supporting research on
regenerative medicine, surging genomics research activities to study diseases,
and advancements in biobanking.
A prevalent trend being witnessed
in the global biobanking equipment market is conservation of newborns’ cord
blood stem cells. The market for biobanking is highly fragmented, owing to
presence of various small and large vendors. Owing to similarity between
products available in the market, vendors are focusing on differentiating their
services based on value-added services, and automation of existing technology,
for thriving in this highly competitive market. According to FactMR’s recent
research, the global market for biobanking equipment is expected to exhibit a
high-single digit CAGR throughout the forecast period 2017 to 2022. Sales of
biobanking equipment worldwide are estimated to surpass US$ 2,000 Mn in
revenues by 2022-end.
Although regenerative medicine is
projected to remain the largest application of biobanking equipment, sales for
application in clinical research will exhibit the highest CAGR through 2022.
Sales of biobanking equipment for application in life science research will
remain relatively lower over the forecast period. Manual storage are poised to
remain sought-after in the global biobanking equipment market. However,
automated storage is expected to register the fastest expansion in the market
through 2022. North America will remain the most attractive market for
biobanking equipment, expanding at 7.6% CAGR through 2022. In addition, the
markets in Japan and Latin America are estimated to witness a parallel expansion,
exhibiting similar CAGRs through 2022.
Blood is expected to be the most
lucrative sample in the market, with sales expanding at the highest CAGR and
accounting for the largest revenues through 2022. In contrast, sales of tissues
are anticipated to exhibit the lowest CAGR through 2022, based on sample type. On
the basis of product, equipment will remain dominant in the market, with sales
poised to exceed US$ 1,300 Mn in revenues by 2022-end. Between consumables, and
software & services, the latter is projected to register a comparatively
faster expansion through 2022.
Competition Tracking
The report has profiled key
players operating in the global biobanking equipment market, which include
Becton, Dickinson and Company, Brooks Automation, Inc., Chart Industries, Inc.,
Greiner Holding AG, Hamilton Company, Merck KGaA, Panasonic Healthcare
Holdings, Promega Corporation, Tecan Trading AG, Qiagen N.V., Thermo Fisher
Scientific Inc., and VWR Corporation.
Ask
Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=250
About FactMRFactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Comments
Post a Comment